Exscientia is a series c plus startup based in United Kingdom. 2 investors tracked.
Exscientia is a startup founded in 2012 based in the United Kingdom. Exscientia has been acquired. Brouky records 4 investors associated with the company.
Exscientia is a technology-driven drug design and development company that utilizes artificial intelligence to create more effective medicines for patients faster. The company combines precision design with integrated experimentation, pioneering the use of AI in drug discovery to progress AI-designed small molecules into clinical settings.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.